(R)-1-(2-Fluorobenzyl)pyrrolidin-3-aminedihydrochloride, 95.0%, 1g

1-(2-Ethoxybenzoyl)piperidin-4-amine hydrochloride, 95%, 50mg

4-(2-Bromoethoxy)-1,2-dimethylbenzene, 97%, 250mg

Methanesulfonic acid ((R)-1-((S)-2-amino-3-methylbutanoyl)pyrrolidin-2-yl)boronic acid (1:1), 95.0%, 100mg

5-Bromofuran-2-carbonitrile, 95.0%, 5g

Organosilica FITC (100nm Diam.)2mg

Cuba de muestra ROTILABO® con tapa a presión, 300 ml, estéril, 240 pieza(s)

3-Bromo-2-ethoxy-5-methylbenzaldehyde, 95+%, 1g

(4S,4'S)-2,2'-(Cyclopropane-1,1-diyl)bis(4-(tert-butyl)-4,5-dihydrooxazole), 97%, 1g

3-{6-Bromo-[1,2,4]triazolo[4,3-a]pyridin-3-yl}pyridine, 1g

H-D-Met-OH, 97%, 1g

1-(3-BROMO-2-HYDROXY-5-METHYLPHENYL)ETHANONE, 95.0%, 100mg

9-methyl-6,9-diazaspiro[4.5]decane-7,10-dione, 95.0%, 500mg